The University of Chicago Header Logo

Connection

Hiroyuki Abe to Middle Aged

Back to Details
This is a "connection" page, showing publications Hiroyuki Abe has written about Middle Aged.
Hiroyuki Abe
Connection Strength
0.730
Middle Aged
  1. Virus-host interactions in carcinogenesis of Epstein-Barr virus-associated gastric carcinoma: Potential roles of lost ARID1A expression in its early stage. PLoS One. 2021; 16(9):e0256440.
    View in: PubMed
    Score: 0.045
  2. Nonmass Enhancement Breast Lesions: Diagnostic Performance of Kinetic Assessment on Ultrafast and Standard Dynamic Contrast-Enhanced MRI in Comparison With Morphologic Evaluation. AJR Am J Roentgenol. 2020 08; 215(2):511-518.
    View in: PubMed
    Score: 0.041
  3. Fast Temporal Resolution Dynamic Contrast-Enhanced MRI: Histogram Analysis Versus Visual Analysis for Differentiating Benign and Malignant Breast Lesions. AJR Am J Roentgenol. 2018 10; 211(4):933-939.
    View in: PubMed
    Score: 0.036
  4. Value of breast MRI for patients with a biopsy showing atypical ductal hyperplasia (ADH). J Magn Reson Imaging. 2017 12; 46(6):1738-1747.
    View in: PubMed
    Score: 0.033
  5. Kinetic Analysis of Benign and Malignant Breast Lesions With Ultrafast Dynamic Contrast-Enhanced MRI: Comparison With Standard Kinetic Assessment. AJR Am J Roentgenol. 2016 Nov; 207(5):1159-1166.
    View in: PubMed
    Score: 0.031
  6. MRI phenotype of breast cancer: Kinetic assessment for molecular subtypes. J Magn Reson Imaging. 2015 Oct; 42(4):920-4.
    View in: PubMed
    Score: 0.028
  7. Diffusion weighted images of metastatic as compared with nonmetastatic axillary lymph nodes in patients with newly diagnosed breast cancer. J Magn Reson Imaging. 2015 Sep; 42(3):771-8.
    View in: PubMed
    Score: 0.028
  8. Importance of a personal history of breast cancer as a risk factor for the development of subsequent breast cancer: results from screening breast MRI. AJR Am J Roentgenol. 2014 Feb; 202(2):289-92.
    View in: PubMed
    Score: 0.026
  9. Decision making for breast lesions initially detected at contrast-enhanced breast MRI. AJR Am J Roentgenol. 2013 Dec; 201(6):1376-85.
    View in: PubMed
    Score: 0.026
  10. Accuracy of axillary lymph node staging in breast cancer patients: an observer-performance study comparison of MRI and ultrasound. Acad Radiol. 2013 Nov; 20(11):1399-404.
    View in: PubMed
    Score: 0.026
  11. Breast cancer detected on an incident (second or subsequent) round of screening MRI: MRI features of false-negative cases. AJR Am J Roentgenol. 2013 Nov; 201(5):1155-63.
    View in: PubMed
    Score: 0.026
  12. Utility of preoperative ultrasound for predicting pN2 or higher stage axillary lymph node involvement in patients with newly diagnosed breast cancer. AJR Am J Roentgenol. 2013 Mar; 200(3):696-702.
    View in: PubMed
    Score: 0.025
  13. Comparing post-operative human breast specimen radiograph and MRI in lesion margin and volume assessment. J Appl Clin Med Phys. 2012 Nov 08; 13(6):3802.
    View in: PubMed
    Score: 0.024
  14. MR-directed ("Second-Look") ultrasound examination for breast lesions detected initially on MRI: MR and sonographic findings. AJR Am J Roentgenol. 2010 Feb; 194(2):370-7.
    View in: PubMed
    Score: 0.020
  15. Axillary lymph nodes suspicious for breast cancer metastasis: sampling with US-guided 14-gauge core-needle biopsy--clinical experience in 100 patients. Radiology. 2009 Jan; 250(1):41-9.
    View in: PubMed
    Score: 0.018
  16. K-means clustering-based analysis of quantitative ultrafast DCE-MRI for predicting breast cancer response to neoadjuvant chemotherapy. J Appl Clin Med Phys. 2026 Jan; 27(1):e70439.
    View in: PubMed
    Score: 0.015
  17. Postmortem computed tomography assessment of intracardiac and intravascular blood clots and gravitational sedimentation: clinical and laboratory associations in 114 in-hospital deaths. Jpn J Radiol. 2025 Sep; 43(9):1465-1478.
    View in: PubMed
    Score: 0.014
  18. Effect of temporal subtraction images on radiologists' detection of lung cancer on CT: results of the observer performance study with use of film computed tomography images. Acad Radiol. 2004 Dec; 11(12):1337-43.
    View in: PubMed
    Score: 0.014
  19. Artificial neural networks (ANNs) for differential diagnosis of interstitial lung disease: results of a simulation test with actual clinical cases. Acad Radiol. 2004 Jan; 11(1):29-37.
    View in: PubMed
    Score: 0.013
  20. Bilateral asymmetry of quantitative parenchymal kinetics at ultrafast DCE-MRI predict response to neoadjuvant chemotherapy in patients with HER2+ breast cancer. Magn Reson Imaging. 2023 12; 104:9-15.
    View in: PubMed
    Score: 0.013
  21. Elucidation of the mechanism of amyloid A and transthyretin formation using mass spectrometry-based absolute quantification. Virchows Arch. 2024 Nov; 485(5):943-946.
    View in: PubMed
    Score: 0.013
  22. Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response. Radiology. 2021 11; 301(2):295-308.
    View in: PubMed
    Score: 0.011
  23. Discriminating low-grade ductal carcinoma in situ (DCIS) from non-low-grade DCIS or DCIS upgraded to invasive carcinoma: effective texture features on ultrafast dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer. 2021 Sep; 28(5):1141-1153.
    View in: PubMed
    Score: 0.011
  24. Programmed cell death protein 1/programmed death ligand 1 but not HER2 is a potential therapeutic target in gastric neuroendocrine carcinoma. Histopathology. 2021 Feb; 78(3):381-391.
    View in: PubMed
    Score: 0.010
  25. Low-dose imaging technique (LITE) MRI: initial experience in breast imaging. Br J Radiol. 2019 Nov; 92(1103):20190302.
    View in: PubMed
    Score: 0.010
  26. Test-retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trial. J Magn Reson Imaging. 2019 06; 49(6):1617-1628.
    View in: PubMed
    Score: 0.009
  27. Ultrafast Dynamic Contrast-Enhanced Breast MRI: Kinetic Curve Assessment Using Empirical Mathematical Model Validated with Histological Microvessel Density. Acad Radiol. 2019 07; 26(7):e141-e149.
    View in: PubMed
    Score: 0.009
  28. Diagnostic value of electric properties tomography (EPT) for differentiating benign from malignant breast lesions: comparison with standard dynamic contrast-enhanced MRI. Eur Radiol. 2019 Apr; 29(4):1778-1786.
    View in: PubMed
    Score: 0.009
  29. Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial. Radiology. 2018 12; 289(3):618-627.
    View in: PubMed
    Score: 0.009
  30. Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers. Clin Cancer Res. 2019 03 15; 25(6):1786-1794.
    View in: PubMed
    Score: 0.009
  31. Lymph node wire localization post-chemotherapy: Towards improving the false negative sentinel lymph node biopsy rate in breast cancer patients. Clin Imaging. 2018 Mar - Apr; 48:69-73.
    View in: PubMed
    Score: 0.009
  32. Gadobutrol-Enhanced Magnetic Resonance Imaging of the Breast in the Preoperative Setting: Results of 2 Prospective International Multicenter Phase III Studies. Invest Radiol. 2016 07; 51(7):454-61.
    View in: PubMed
    Score: 0.008
  33. Ultrafast Bilateral DCE-MRI of the Breast with Conventional Fourier Sampling: Preliminary Evaluation of Semi-quantitative Analysis. Acad Radiol. 2016 09; 23(9):1137-44.
    View in: PubMed
    Score: 0.008
  34. Comparison of dynamic contrast-enhanced MRI parameters of breast lesions at 1.5 and 3.0?T: a pilot study. Br J Radiol. 2015 May; 88(1049):20150021.
    View in: PubMed
    Score: 0.007
  35. Evaluation of Kinetic Entropy of Breast Masses Initially Found on MRI using Whole-lesion Curve Distribution Data: Comparison with the Standard Kinetic Analysis. Eur Radiol. 2015 Aug; 25(8):2470-8.
    View in: PubMed
    Score: 0.007
  36. Using quantitative image analysis to classify axillary lymph nodes on breast MRI: a new application for the Z 0011 Era. Eur J Radiol. 2015 Mar; 84(3):392-397.
    View in: PubMed
    Score: 0.007
  37. Intratumoral heterogeneity of the distribution of kinetic parameters in breast cancer: comparison based on the molecular subtypes of invasive breast cancer. Breast Cancer. 2015 Sep; 22(5):496-502.
    View in: PubMed
    Score: 0.007
  38. Observer study of a prototype clinical decision support system for breast cancer diagnosis using dynamic contrast-enhanced MRI. AJR Am J Roentgenol. 2013 Feb; 200(2):277-83.
    View in: PubMed
    Score: 0.006
  39. A prospective study of the utility of magnetic resonance imaging in determining candidacy for partial breast irradiation. Int J Radiat Oncol Biol Phys. 2013 Mar 01; 85(3):615-22.
    View in: PubMed
    Score: 0.006
  40. Non-contrast enhanced MRI for evaluation of breast lesions: comparison of non-contrast enhanced high spectral and spatial resolution (HiSS) images versus contrast enhanced fat-suppressed images. Acad Radiol. 2011 Dec; 18(12):1467-74.
    View in: PubMed
    Score: 0.006
  41. Characterizing early contrast uptake of ductal carcinoma in situ with high temporal resolution dynamic contrast-enhanced MRI of the breast: a pilot study. Phys Med Biol. 2010 Oct 07; 55(19):N473-85.
    View in: PubMed
    Score: 0.005
  42. Breast cancers not detected at MRI: review of false-negative lesions. AJR Am J Roentgenol. 2010 Jun; 194(6):1674-9.
    View in: PubMed
    Score: 0.005
  43. Potential usefulness of similar images in the differential diagnosis of clustered microcalcifications on mammograms. Radiology. 2009 Dec; 253(3):625-31.
    View in: PubMed
    Score: 0.005
  44. DCEMRI of breast lesions: is kinetic analysis equally effective for both mass and nonmass-like enhancement? Med Phys. 2008 Jul; 35(7):3102-9.
    View in: PubMed
    Score: 0.004
  45. Differentiation between benign and malignant breast lesions detected by bilateral dynamic contrast-enhanced MRI: a sensitivity and specificity study. Magn Reson Med. 2008 Apr; 59(4):747-54.
    View in: PubMed
    Score: 0.004
  46. Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade. Radiology. 2007 Dec; 245(3):684-91.
    View in: PubMed
    Score: 0.004
  47. Fat suppression with spectrally selective inversion vs. high spectral and spatial resolution MRI of breast lesions: qualitative and quantitative comparisons. J Magn Reson Imaging. 2006 Dec; 24(6):1311-5.
    View in: PubMed
    Score: 0.004
  48. Diagnosis of suspicious breast lesions using an empirical mathematical model for dynamic contrast-enhanced MRI. Magn Reson Imaging. 2007 Jun; 25(5):593-603.
    View in: PubMed
    Score: 0.004
  49. High spectral and spatial resolution MRI of breast lesions: preliminary clinical experience. AJR Am J Roentgenol. 2006 Jan; 186(1):30-7.
    View in: PubMed
    Score: 0.004
  50. Computer-aided detection of peripheral lung cancers missed at CT: ROC analyses without and with localization. Radiology. 2005 Nov; 237(2):684-90.
    View in: PubMed
    Score: 0.004
  51. Radiologists' performance for differentiating benign from malignant lung nodules on high-resolution CT using computer-estimated likelihood of malignancy. AJR Am J Roentgenol. 2004 Nov; 183(5):1209-15.
    View in: PubMed
    Score: 0.003
  52. Malignant versus benign nodules at CT screening for lung cancer: comparison of thin-section CT findings. Radiology. 2004 Dec; 233(3):793-8.
    View in: PubMed
    Score: 0.003
  53. Low-dose computed tomography screening for lung cancer in a general population: characteristics of cancer in non-smokers versus smokers. Acad Radiol. 2003 Sep; 10(9):1013-20.
    View in: PubMed
    Score: 0.003
  54. Lung cancers missed at low-dose helical CT screening in a general population: comparison of clinical, histopathologic, and imaging findings. Radiology. 2002 Dec; 225(3):673-83.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.